Genmark Diagnostics, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$86Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
23clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Lisa Stoneking | Tucson, AZ | Emergency Medicine | $23,915.60 |
| Benjamin Pinsky | Stanford, CA | Anatomic Pathology & Clinical Pathology | $10,219.92 |
| Kimberle Chapin | Providence, RI | Medical Microbiology | $8,429.60 |
| Bobbi Pritt | Rochester, MN | Medical Microbiology | $7,000.00 |
| Michael Mansour | Boston, MA | Internal Medicine | $5,926.68 |
| Larissa May | Washington, DC | Emergency Medicine | $5,478.19 |
| Sixto Leal | Birmingham, AL | Clinical Pathology/Laboratory Medicine | $3,659.66 |
| William Stauffer | Minneapolis, MN | Infectious Disease | $3,500.00 |
| Roy Chemaly | Houston, TX | Infectious Disease | $2,815.76 |
| Karen Carroll | Baltimore, MD | Anatomic Pathology & Clinical Pathology | $2,815.56 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.